GlaxoSmithKline Pakistan Market Cap

GlaxoSmithKline Pakistan has a market cap or net worth of 134.78 billion as of August 14, 2025. Its market cap has increased by 207.69% in one year.

Market Cap

134.78B

Enterprise Value

128.96B

Revenue

61.15B

Ranking

n/a

PE Ratio

16.65

Stock Price

423.23

Market Cap Chart

Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 134.78B, an increase of 3,474.39%. That is a compound annual growth rate of 12.27%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	134.78B	6.63%
Dec 31, 2024	126.40B	378.26%
Dec 29, 2023	26.43B	-5.45%
Dec 30, 2022	27.95B	-35.70%
Dec 31, 2021	43.47B	-28.84%
Dec 31, 2020	61.09B	19.47%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbott Laboratories (Pakistan)	113.47B
Highnoon Laboratories	60.74B
AGP Limited	58.82B
The Searle Company	49.14B
Shifa International Hospitals	35.57B
Citi Pharma	20.10B
Ferozsons Laboratories	18.30B
Otsuka Pakistan	3.51B

Market Cap Rankings